0,917  0,002  NOS2 expression inhibitor
0,840  0,002  Melanin inhibitor
0,848  0,011  Apoptosis agonist
0,817  0,004  Caspase 3 stimulant
0,805  0,003  Skin whitener
0,801  0,005  Antileukemic
0,781  0,006  Chemopreventive
0,740  0,005  Antioxidant
0,733  0,004  Antiprotozoal (Leishmania)
0,725  0,017  Antineoplastic (breast cancer)
0,724  0,018  Transcription factor NF kappa B inhibitor
0,701  0,006  Proliferative diseases treatment
0,676  0,007  NOS3 expression inhibitor
0,675  0,021  Antineoplastic (lung cancer)
0,656  0,005  Antineoplastic (glioma)
0,684  0,034  Antiinflammatory
0,649  0,008  AR expression inhibitor
0,645  0,008  Nitric oxide antagonist
0,640  0,009  Antiosteoporotic
0,624  0,014  Antineoplastic (ovarian cancer)
0,592  0,004  NOS3 expression enhancer
0,592  0,006  Antineoplastic (glioblastoma multiforme)
0,593  0,008  Hypoxia-inducible factor 1 alpha inhibitor
0,587  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,594  0,015  Bone diseases treatment
0,587  0,009  Free radical scavenger
0,580  0,010  CYP2C19 inhibitor
0,570  0,004  Protein-tyrosine phosphatase inhibitor
0,558  0,017  Antineoplastic (melanoma)
0,567  0,027  Antineoplastic (colorectal cancer)
0,554  0,015  Cardioprotectant
0,558  0,026  Antineoplastic (colon cancer)
0,535  0,007  Monophenol monooxygenase inhibitor
0,505  0,003  Electron transport complex I inhibitor
0,505  0,025  Antihypercholesterolemic
0,484  0,013  Vasodilator
0,483  0,017  Hypoglycemic
0,480  0,017  CYP1A2 inhibitor
0,469  0,011  Antihelmintic
0,465  0,012  Antineoplastic (lymphocytic leukemia)
0,459  0,007  Lipid peroxidase inhibitor
0,464  0,015  Antimitotic
0,442  0,004  Estrogen agonist
0,455  0,019  Antiparasitic
0,461  0,027  CTGF expression inhibitor
0,459  0,026  Apoptosis antagonist
0,461  0,029  Spasmolytic
0,458  0,029  Hepatic disorders treatment
0,448  0,026  UGT1A9 substrate
0,467  0,051  Antibacterial
0,441  0,030  Antineoplastic (brain cancer)
0,414  0,003  Estrogen receptor beta agonist
0,468  0,061  Alzheimer's disease treatment
0,455  0,048  Histamine release inhibitor
0,404  0,004  Estrogen antagonist
0,420  0,023  Antineoplastic (lymphoma)
0,425  0,031  ICAM1 expression inhibitor
0,398  0,004  Estrogen receptor alpha antagonist
0,398  0,004  Estrogen receptor beta antagonist
0,445  0,054  5 Hydroxytryptamine release inhibitor
0,418  0,033  Lipoxygenase inhibitor
0,439  0,064  TNF expression inhibitor
0,388  0,013  Antihypotensive
0,427  0,054  Immunosuppressant
0,414  0,049  Prostate cancer treatment
0,398  0,036  Cytotoxic
0,383  0,025  Vascular (periferal) disease treatment
0,388  0,035  Cytostatic
0,368  0,016  Hepatoprotectant
0,367  0,026  Antihypertriglyceridemic
0,387  0,049  Antifungal
0,348  0,012  UGT2B15 substrate
0,356  0,032  UGT1A6 substrate
0,357  0,038  Antipyretic
0,357  0,038  Antiprotozoal (Trypanosoma)
0,388  0,073  Antiprotozoal
0,411  0,105  Caspase 9 stimulant
0,321  0,016  Topoisomerase II inhibitor
0,355  0,053  Vasodilator, coronary
0,347  0,046  Antineoplastic (cervical cancer)
0,324  0,027  UGT1A1 substrate
0,339  0,044  DNA damaging
0,366  0,072  CYP3A4 substrate
0,344  0,055  Lipoprotein disorders treatment
0,299  0,010  Heat shock protein 90 antagonist
0,305  0,020  MAO inhibitor
0,285  0,003  Neuraminidase inhibitor
0,379  0,103  Cyclophilin D inhibitor
0,379  0,103  Antidiabetic
0,321  0,046  Antiamyloidogenic
0,274  0,005  Postmenopausal disorders treatment
0,305  0,039  Antineoplastic (sarcoma)
0,300  0,035  UDP-glucuronosyltransferase substrate
0,310  0,057  UGT2B4 substrate
0,272  0,021  Protein kinase stimulant
0,306  0,056  Chemoprotective
0,280  0,031  Antimutagenic
0,297  0,050  GST M1-1 substrate
0,310  0,072  CYP3A4 inhibitor
0,248  0,015  Cystathionine beta-synthase inhibitor
0,258  0,029  UGT1A3 substrate
0,254  0,030  Contraceptive
0,225  0,004  Neuraminidase (influenza) inhibitor
0,330  0,120  Antiparkinsonian
0,261  0,052  Carcinogenic
0,227  0,020  Topoisomerase I inhibitor
0,271  0,064  Antidiabetic symptomatic
0,236  0,032  Amylase inhibitor
0,229  0,025  Cyclooxygenase 1 inhibitor
0,245  0,041  Neurotrophic factor enhancer
0,251  0,049  RNA-directed DNA polymerase inhibitor
0,211  0,009  Papain-like protease (SARS coronavirus) inhibitor
0,218  0,018  Antihemorrhagic
0,284  0,084  Antiischemic
0,269  0,070  Cardiotonic
0,207  0,009  Actinic keratosis treatment
0,221  0,023  SULT1A3 substrate
0,211  0,014  Beta amyloid protein antagonist
0,211  0,013  Topoisomerase II alpha inhibitor
0,217  0,024  Psychosexual dysfunction treatment
0,246  0,055  Antiarrhythmic
0,259  0,072  5 Hydroxytryptamine uptake stimulant
0,238  0,051  Antiviral (Influenza)
0,201  0,014  Carbonic anhydrase XIII inhibitor
0,214  0,029  Antidiarrheal
0,199  0,014  Contraceptive female
0,258  0,075  Antineoplastic (renal cancer)
0,212  0,031  Genotoxic
0,227  0,052  Nitric-oxide synthase stimulant
0,208  0,035  UGT2B9 substrate
0,301  0,131  15-Lipoxygenase inhibitor
0,255  0,089  CYP2C19 substrate
0,219  0,054  P-glycoprotein inhibitor
0,219  0,054  UGT2B7 substrate
0,280  0,119  Ulceration
0,218  0,059  Pneumotoxic
0,210  0,054  Diabetic retinopathy treatment
0,236  0,081  Cardiovascular analeptic
0,220  0,067  VCAM1 expression inhibitor
0,204  0,053  Prostatic (benign) hyperplasia treatment
0,281  0,132  CYP2C9 inhibitor
0,189  0,040  Tubulin antagonist
0,177  0,029  MAO B inhibitor
0,211  0,064  Mutagenic
0,212  0,065  Platelet adhesion inhibitor
0,155  0,010  Ornithine decarboxylase inhibitor
0,252  0,107  Antimycobacterial
0,176  0,032  Glutathione S-transferase substrate
0,182  0,041  Renal failure treatment
0,243  0,105  Respiratory analeptic
0,140  0,005  Estrogen receptor alpha agonist
0,166  0,037  Farnesoid X receptor antagonist
0,193  0,067  VEGF expression inhibitor
0,265  0,141  GABA C receptor rho-3 antagonist
0,168  0,045  Acetylcholinesterase inhibitor
0,159  0,037  Liver cirrhosis treatment
0,132  0,014  Lipase inhibitor
0,139  0,022  NAD(P)H dehydrogenase (quinone) inhibitor
0,143  0,028  Dementia treatment
0,184  0,072  Antipruritic, non-allergic
0,139  0,028  Vascular dementia treatment
0,139  0,029  Creatine kinase inhibitor
0,167  0,058  Cyclooxygenase inhibitor
0,254  0,145  CYP2C9 substrate
0,175  0,068  Toxic, respiratory center
0,165  0,062  Carcinogenic, group 1
0,175  0,074  Succinate dehydrogenase inhibitor
0,142  0,041  5-Lipoxygenase inhibitor
0,126  0,026  SULT1E1 substrate
0,176  0,078  LDLR expression enhancer
0,215  0,119  Antidiabetic (type 2)
0,160  0,073  Peroxidase inhibitor
0,094  0,008  Postcoital contraceptive
0,217  0,131  CYP1A2 substrate
0,265  0,179  Alpha-glucosidase inhibitor
0,189  0,103  Hypolipemic
0,249  0,164  Antipruritic, allergic
0,091  0,007  Acetyl-CoA transferase 2 inhibitor
0,172  0,088  Sedative
0,196  0,113  Tumour necrosis factor alpha release inhibitor
0,207  0,128  Streptokinase A inhibitor
0,157  0,079  Interleukin 6 antagonist
0,143  0,065  Heat shock protein 70 antagonist
0,115  0,038  Opioid antagonist
0,145  0,068  Antineoplastic (squamous cell carcinoma)
0,192  0,116  Antineoplastic (liver cancer)
0,232  0,156  GST A substrate
0,115  0,042  Antihypermotility
0,076  0,005  Retinoic acid alpha receptor agonist
0,101  0,030  Na+ K+ transporting ATPase inhibitor
0,090  0,019  Androgen agonist
0,163  0,094  Sensitization
0,097  0,028  Leukotriene synthesis inhibitor
0,078  0,009  Leukotriene C antagonist
0,127  0,059  Cholesterol synthesis inhibitor
0,101  0,033  Antiprotozoal activity enhancer
0,201  0,133  Analeptic
0,110  0,042  Antineoplastic antibiotic
0,168  0,102  CYP2B6 inhibitor
0,129  0,063  Antineoplastic (uterine cancer)
0,070  0,004  Sodium/glucose cotransporter 2 inhibitor
0,114  0,049  Bronchodilator
0,077  0,013  Potassium channel Kv1.3 blocker
0,109  0,047  Prolactin inhibitor
0,088  0,027  Secretase beta inhibitor
0,106  0,046  Alcohol dehydrogenase inhibitor
0,191  0,130  Radioprotector
0,117  0,059  SULT1A1 substrate
0,142  0,084  Cholinergic
0,077  0,020  Transcription factor RelA inhibitor
0,111  0,054  Urease inhibitor
0,111  0,055  Beta glucuronidase inhibitor
0,138  0,082  Ca2+-transporting ATPase inhibitor
0,160  0,105  Antirickettsial
0,085  0,032  HIV-1 integrase (3'-Processing) inhibitor
0,146  0,094  Prostate disorders treatment
0,087  0,037  SULT1A2 substrate
0,066  0,016  Opioid kappa receptor agonist
0,137  0,089  Antiviral (Herpes)
0,087  0,042  Ca(v)3.1 blocker
0,104  0,059  Sulfotransferase substrate
0,050  0,005  Sodium/glucose cotransporter inhibitor
0,058  0,014  Retinoid X receptor agonist
0,098  0,055  Bile acid receptor antagonist
0,105  0,064  UGT2B1 substrate
0,119  0,079  Gastritis treatment
0,103  0,064  Alpha 2c adrenoreceptor antagonist
0,155  0,117  Abortion inducer
0,095  0,057  ABCA1 expression enhancer
0,045  0,008  Estrogen-related receptor beta antagonist
0,073  0,037  Leukotriene antagonist
0,079  0,043  Antitreponemal
0,071  0,035  HIV-1 integrase (Strand Transfer) inhibitor
0,167  0,134  Antineoplastic (non-small cell lung cancer)
0,050  0,017  Hypogonadism treatment
0,108  0,077  Microtubule formation inhibitor
0,088  0,057  Antineoplastic alkaloid
0,054  0,024  Carbonic anhydrase VII inhibitor
0,094  0,065  Xanthine oxidase inhibitor
0,130  0,101  UGT1A4 substrate
0,133  0,104  MAP kinase kinase 4 inhibitor
0,078  0,051  Keratolytic
0,129  0,103  Adenylate cyclase stimulant
0,095  0,071  Anabolic
0,095  0,071  Gastric antisecretory
0,156  0,134  Aldehyde oxidase inhibitor
0,062  0,040  Aromatase inhibitor
0,092  0,072  UGT2B11 substrate
0,082  0,063  Androgen antagonist
0,058  0,042  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,037  0,023  Nociceptin (N/OFQ) receptor antagonist
0,069  0,056  Histone deacetylase SIRT1 stimulant
0,069  0,056  Histone deacetylase stimulant
0,037  0,024  Progesterone antagonist
0,128  0,115  Arachidonic acid antagonist
0,051  0,039  Opioid agonist
0,068  0,057  Phosphodiesterase 4D inhibitor
0,066  0,057  SULT2A1 substrate
0,141  0,132  Sepsis treatment
0,127  0,120  Liver fibrosis treatment
0,090  0,083  Carbonic anhydrase XV inhibitor
0,023  0,016  Retinoic acid receptor agonist
0,045  0,039  Mineralocorticoid receptor antagonist
0,104  0,100  Cyclooxygenase 2 inhibitor
0,157  0,155  Myocardial infarction treatment
0,117  0,115  Insulin secretagoues
0,072  0,071  Opioid kappa receptor antagonist
0,072  0,072  Carcinogenic, group 2A

